Cherwell Provides Practical Microbiolo?gical Solutions at PHSS 2013
Cherwell Laboratories will be offering expert knowledge and demonstrating their comprehensive range of specialist environmental monitoring and process validation products at the forthcoming PHSS Annual Members Conference 2013, Microbial Aspects of Cleanroom Manufacture.
The annual conference, to be held at Wychwood Park Hotel, Crewe on 9 & 10 October 2013, coincides with the release of the new PHSS Bio-contamination technical monograph 20. Presentations throughout the event, which is free-to-attend for PHSS members, will feature key aspects of Bio-contamination management as detailed in this new publication.
Andrew Barrow, Sales Manager, Cherwell Laboratories commented: “This event will provide an invaluable insight into Bio-contamination management and the new PHSS technical monograph 20.” He added, “Cherwell will be available throughout the event to share practical ideas with delegates on their specific environmental monitoring or process validation requirements.”
With more than 40 years’ experience in the pharmaceutical and healthcare sciences industry, Cherwell Laboratories has developed a specialist range of products to meet the specific requirements of environmental monitoring and process validation. The Cherwell range includes Redipor prepared media; a selection of petri dishes, settle plates, bottled media, broth bags, vials and ampoules. Other products in the range include SAS microbial air samplers for a variety of environmental monitoring applications and biological indicators for the validation of sterilisation processes.
Related News
-
News Novartis signs US$3.2 bn subcutaneous delivery deal with Alteogen
Swiss pharma giant secures access to Korean biotech's ALT-B4 hyaluronidase platform in milestone-heavy agreement, marking Alteogen's fourth major licensing deal of 2026 as competition intensifies in the subcutaneous drug delivery space.
-
News Women in Pharma: The philosophy of pharmaceutical leadership
In this latest instalment of our Women in Pharma series, we sit down with Clarissa Sowemimo-Coker, Chief Strategy Officer at Ambrose Healthcare and CPHI Middle East Advisory Board Member.
-
News The PSCI Supplier Partnership - Collaboration for Responsible Supply Chains
About the Pharmaceutical Supply Chain Initiative The Pharmaceutical Supply Chain Initiative (PSCI) is the leading, member-led association for pharmaceutical companies working collaboratively to build responsible supply chains. Founded in 2006 and es... -
News AstraZeneca shares plunge 8.9% after reports of BMS talks
Britain's largest drugmaker lost more than GBP£17 billion in market value following reports of preliminary merger discussions with Bristol Myers Squibb that could create a pharmaceutical giant worth nearly US$400 billion, though investors rem... -
News GSK announces £400 million investment in new Cambridge R&D centre
Pharmaceutical giant to establish flagship research facility on Cambridge Biomedical Campus as part of strategic pipeline acceleration
-
News The CPHI Sustainability Summit - Where Conversation Becomes Collaboration
The Report Was Never the Destination - “The future of pharmaceutical sustainability won’t be shaped by individual organisations working in isolation. It will be shaped by partnerships, shared expertise and the willingness to work diffe... -
News Trump's generic drug tariffs set to reshape global pharmaceutical supply chains
The US president has announced plans to impose tariffs of up to 200% on imported generic medicines from August 2028, giving manufacturers a two-year window to establish domestic production facilities. The move threatens to upend a global supply chain t... -
News Building Safer, More Responsible Pharmaceutical Supply Chains: PSCI Global Audit Insights
The Pharmaceutical Supply Chain Initiative (PSCI) has released its seventh annual Audit Findings Analysis Report, offering unprecedented insights into supplier practices across the global pharmaceutical and healthcare industry.With a record-breaking 24...